CompoAtlas

pharmaPRC

Natural health product licensed in Canada

Other names
Ostinol Insta-Joint Relief
Licence holder
7120044 Canada Ltd.
NPN or DIN-HM
80065292
Status
Inactive licence
Licence date
19 November 2015
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Dichlorhydrate de 4-(2-aminoéthyl)imidazole

Source : Dichlorhydrate d'histamine

0.025 %
2-méthoxycarbonyl)phénol

Source : Salicylate de méthyle

5 %

Non-medicinal ingredients

Acétate de d-alpha tocophéryle, Poly(acrylamide), EDTA de tétrasodium, Huile de graine de Carthamus Tinctorius (Carthame), Butylène glycol, Palmitate de cétyle, Isoparaffine en C13 à 14, Méthylsulfonylméthane, Diméthicone, Chlorhydrate de glucosamine, Méthylisothiazolinone, Olivate de sorbitan, Jus de feuilles d'Aloe Barbadensis, Laureth-7, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Eau, Olivate de cétéaryle

PopulationAgeQuantity per servingFrequency
Adultes, adolescents et enfantsminimum: 2 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80065292

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line